REVIEW PAPER
Potential role of the urinary microbiome in female urinary incontinence – a scoping review
More details
Hide details
1
2nd Department of Gynaecology, Medical University, Lublin, Poland
2
Department of Experimental Immunology, Medical University, Lublin, Poland
Corresponding author
Paweł Miotła
2nd Department of Gynaecology, Medical University of Lublin, Poland, ul. Jaczewskiego 8, Lublin, 20-954, Poland
KEYWORDS
TOPICS
ABSTRACT
Introduction and objective:
Urinary incontinence (UI) is defined as any involuntary leakage of urine and may affect up to half of women, depending on the population and methodology used. Consequently, there is an ongoing need for objective markers that could improve phenotyping of women with lower urinary tract symptoms (LUTS) and support more targeted management. A major conceptual shift occurred after the demonstration that urine is not sterile. Using culture-independent methods (16S rRNA sequencing) and enhanced quantitative urine culture (EQUC), resident microbial communities have been identified in the female bladder.
Review methods:
The aim of the scoping review is to map and summarize evidence from 2012–2024 on the relationship between the urinary microbiome and female UI, with particular emphasis on differences reported between UI subtypes (SUI, UUI/OAB, and MUI), and to identify key gaps in knowledge, and methodological challenges relevant to future diagnostic and therapeutic research.
Brief description of the state of knowledge:
Pearce et al. compared catheterized urine from women with and without UUI symptoms using both 16S rRNA sequencing and EQUC. They reported lower overall abundance of Lactobacillus in the UUI group, with enrichment of genera including Gardnerella, and differences in Lactobacillus species distribution (e.g., L. gasseri more frequent in UUI vs. L. crispatus more frequent in controls).
Summary:
Evidence accumulated over the last 12 years confirms that urine in healthy women is not sterile and that urgency-predominant phenotypes (OAB/UUI) most consistently differ from asymptomatic controls in the structure of the urinary microbiome community. Reported patterns most often include reduced Lactobacillus dominance and/or increased prevalence of genera such as Gardnerella, Aerococcus, Proteus, or Enterobacteriaceae.
REFERENCES (44)
1.
Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association/International Continence Society joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26.
2.
Harding CK, Lapitan MC, Arlandis S, et al. European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence. Eur Urol. 2022/2023; published online.
3.
American Urological Association; Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction. The AUA/SUFU Guideline on the Diagnosis and Treatment of Idiopathic Overactive Bladder. 2024.
4.
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167–178.
5.
Wolfe AJ, Toh E, Shibata N, et al. Evidence of uncultivated bacteria in the adult female bladder. J Clin Microbiol. 2012;50:1376–1383.
6.
Hilt EE, McKinley K, Pearce MM, et al. Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol. 2014;52(3):871–876.
https://doi.org/10.1128/JCM.02....
7.
Pearce MM, Hilt EE, Rosenfeld AB, et al. The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. mBio. 2014;5:e01283–14.
https://doi.org/10.1128/mBio.0....
8.
Ford AA, Veit-Rubin N, Cardozo L, Khullar V. Is the microbiome influencing patient care in lower urinary tract dysfunction? Report from the ICI-RS 2017. Neurourol Urodyn. 2018;37(Suppl):S93–S98.
9.
Govender Y, Gabriel I, Minassian V, Fichorova R. The current evidence on the association between the urinary microbiome and urinary incontinence in women. Front Cell Infect Microbiol. 2019;9:133.
10.
Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, et al. The urinary tract microbiome in health and disease. Eur Urol Focus. 2018;4(1):128–138.
11.
Antunes-Lopes T, Vale L, Coelho AM, et al. The role of urinary microbiota in lower urinary tract dysfunction: a systematic review. Eur Urol Focus. 2020;6(2):361–369.
12.
Wolfe AJ, Brubaker L. Urobiome updates: advances in urinary microbiome research. Nat Rev Urol. 2019;16(2):73–74.
13.
Jacobsen GE, Amin K. Our knowledge of the relationship of the urinary microbiome and overactive bladder: past, present, future. Curr Bladder Dysfunct Rep. 2023;18:285–292.
https://doi.org/10.1007/s11884....
14.
Shaker P, Roshani Z, Timajchi E, et al. The role of urinary microbiome analysis in the diagnostic approach and management of urinary incontinence: a systematic review. Life. 2025;15(2):309.
https://doi.org/10.3390/life15....
15.
Tricco AC, Lillie E, Zarin W, et al. PRISMA Extension for Scoping Reviews: checklist and explanation. Ann Intern Med. 2018;169(7):467–473.
16.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
https://doi.org/10.1136/bmj.n7....
17.
Curtiss N, Balachandran A, Krska L, et al. A case controlled study examining the bladder microbiome in women with overactive bladder and healthy controls. Eur J Obstet Gynecol Reprod Biol. 2017;214:31–35.
18.
Wu P, Chen Y, Zhao J, et al. Urinary microbiome and psychological factors in women with overactive bladder. Front Cell Infect Microbiol. 2017;7:488.
19.
Gill K, Kang R, Sathiananthamoorthy S, et al. A blinded observational cohort study of the microbiological ecology associated with pyuria and overactive bladder symptoms. Int Urogynecol J. 2018;29:1493–1500.
20.
Javan Balegh Marand A, Baars C, Heesakkers J, et al. Differences in the urinary microbiome of patients with overactive bladder syndrome with and without detrusor overactivity on urodynamic measurements. Life. 2023;13(5):1199.
21.
Kaya E, Şahinkanat T, Aral M. Investigation of bladder microbiota in female patients with overactive bladder syndrome. Urology Research and Practice. 2025;50(5):310–315.
22.
Sun Q, Li L, Zhou H, et al. The detection of urinary viruses is associated with aggravated symptoms and altered bacteriome in female with overactive bladder. Front Microbiol. 2022;13:984234.
23.
Pearce MM, Zilliox MJ, Rosenfeld AB, et al. The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol. 2015;213:347.e1–347.e11.
24.
Karstens L, Asquith M, Davin S, et al. Does the urinary microbiome play a role in urgency urinary incontinence and its severity? Front Cell Infect Microbiol. 2016;6:78.
25.
Thomas-White KJ, Hilt EE, Fok C, et al. Incontinence medication response relates to the female urinary microbiota. Int Urogynecol J. 2016;27:723–733.
26.
Chen Z, Phan MD, Bates LJ, et al. The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection. Int Urogynecol J. 2018;29:1775–1782.
27.
Abbasian B, Shair A, O’Gorman DB, et al. Potential role of extracellular ATP released by bacteria in bladder infection and contractility. mSphere. 2019;4:e00439–19.
28.
Nardos R, Leung ET, Dahl EM, et al. Network-based differences in the vaginal and bladder microbial communities between women with and without urgency urinary incontinence. Front Cell Infect Microbiol. 2022;12:759156.
https://doi.org/10.3389/fcimb.....
29.
Halverson T, Mueller ER, Brubaker L, Wolfe AJ. Urobiome changes differ based on OAB treatment in adult females. Int Urogynecol J. 2023;34(6):1271–1277.
https://doi.org/10.1007/s00192....
30.
Mueller MG, Das P, Andy U, et al. Longitudinal urinary microbiome characteristics in women with urgency urinary incontinence undergoing sacral neuromodulation. Int Urogynecol J. 2023;34(2):517–525.
https://doi.org/10.1007/s00192....
31.
Gabriel I, Delaney ML, Au M, et al. Impact of microbiota and host immunologic response on the efficacy of anticholinergic treatment for urgency urinary incontinence. Int Urogynecol J. 2023;34:3041–3050.
https://doi.org/10.1007/s00192....
32.
Thomas-White KJ, Kliethermes S, Rickey L, et al. Evaluation of the urinary microbiota of women with uncomplicated stress urinary incontinence. Am J Obstet Gynecol. 2017;216:55.e1–55.e16.
33.
Fok CS, Gao X, Lin H, et al. Urinary symptoms are associated with certain urinary microbes in urogynecologic surgical patients. Int Urogynecol J. 2018;29:1765–1771.
34.
Thomas-White KJ, Gao X, Lin H, et al. Urinary microbes and postoperative urinary tract infection risk in urogynecologic surgical patients. Int Urogynecol J. 2018;29:1797–1805.
35.
Zhang M, Zhou Y, Yao S, et al. Effect of stress urinary incontinence on vaginal microbial communities. BMC Microbiol. 2024;24(1):112.
https://doi.org/10.1186/s12866....
36.
Komesu YM, Richter HE, Carper B, et al. The urinary microbiome in women with mixed urinary incontinence compared to similarly aged controls. Int Urogynecol J. 2018;29:1785–1795.
37.
Komesu YM, Dinwiddie DL, Richter HE, et al. Defining the relationship between vaginal and urinary microbiomes. Am J Obstet Gynecol. 2020;222(2):154.e1–154.e10.
38.
Carnes MU, Siddiqui NY, Karstens L, et al. Urinary microbiome community types associated with urinary incontinence severity in women. Am J Obstet Gynecol. 2024;230(3):344.e1–344.e20.
https://doi.org/10.1016/j.ajog....
39.
Thomas-White K, Taege S, Limeira R, et al. Vaginal estrogen therapy is associated with increased Lactobacillus in the urine of postmenopausal women with overactive bladder symptoms. Am J Obstet Gynecol. 2020;223(5):727.e1–727.e11.
40.
Saenz CN, Neugent ML, De Nisco NJ. The human urinary microbiome and its potential role in urinary tract infections. Eur Urol Focus. 2024/2025.
https://doi.org/10.1016/j.euf.....
41.
Ackerman AL, Chai TC. The bladder is not sterile: an update on the urinary microbiome. Curr Bladder Dysfunct Rep. 2019;14:331–341.
42.
Cumpanas AA, Bratu OG, Bardan RT, et al. Urinary microbiota — are we ready for prime time? A literature review of study methods’ critical steps in avoiding contamination and minimizing biased results. Diagnostics. 2020;10(6):343.
43.
Kim JK, Song SH, Jung G, et al. Possibilities and limitations of using low biomass samples for urologic disease and microbiome research. Prostate Int. 2022;10(4):169–180.
44.
Davis NM, Proctor DM, Holmes SP, et al. Simple statistical identification and removal of contaminant sequences in marker-gene and metagenomics data. Microbiome. 2018;6:226.